Forbes Medi-Tech

Forbes restructures

Forbes restructures

Canadian company Forbes Medi-Tech has announced several changes in
the company'soperations and management structure, and is to
outsource its research to universities and contract research
organisations.

Sterols agreement for Forbes

Sterols agreement for Forbes

Forbes Medi-Tech, a Canadian developer of nutraceuticals and
pharmaceuticals has received two-year sterols supply agreements
valued at up to C$40 million (€26m) from undisclosed customers,
reports Dow Jones this week.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers